Velpatasvir and Sofosbuvir: How Will We Use a New Drug When the Old Agents Work Well?

Clinical Liver Disease - United Kingdom
doi 10.1002/cld.566
Full Text
Abstract

Available in full text

Categories
Hepatology
Date
Authors
Publisher

Wiley

Related search

When Will We Ever Learn?

Annales Universitatis Mariae Curie-Sklodowska, sectio FF, Philologia
2017English

When Will We Leave Iraq?

2004English

Sofosbuvir and Velpatasvir: A Complete Pan-Genotypic Treatment for HCV Patients

Turkish Journal of Gastroenterology
Gastroenterology
2016English

How Will NICE's Budget Impact Test Affect New Drug Availability?

Prescriber
Pharmacology
2017English

Analyzing a Piece of Teaching Through the Lens of the ABCs of How We Learn: 26 Scientifically Proven Approaches, How They Work and When to Use Them

Excelsior: Leadership in Teaching and Learning
2019English

How Well Did We Do?

SecEd
2018English

Effectiveness of Ledipasvir/Sofosbuvir and Sofosbuvir/Velpatasvir in People Who Inject Drugs and/or Those in Opioid Agonist Therapy

Hepatology Communications
Hepatology
2019English

How Will Technology and Society Work Together?

English

How We Talk About the Work Is the Work

Performance Research
Visual ArtsPerforming Arts
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy